Investigation of TRPV1 gene expression in bipolar disorder and its association with CB1 and MOR gene expression
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:79 |
|---|---|
| Enthalten in: |
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology - 79(2024) vom: 01. Feb., Seite 19-21 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Escelsior, Andrea [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Letter |
|---|
| Anmerkungen: |
Date Completed 06.02.2024 Date Revised 06.02.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.euroneuro.2023.10.005 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM36552185X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM36552185X | ||
| 003 | DE-627 | ||
| 005 | 20240206232035.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.euroneuro.2023.10.005 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1282.xml |
| 035 | |a (DE-627)NLM36552185X | ||
| 035 | |a (NLM)38061295 | ||
| 035 | |a (PII)S0924-977X(23)00704-6 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Escelsior, Andrea |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Investigation of TRPV1 gene expression in bipolar disorder and its association with CB1 and MOR gene expression |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 06.02.2024 | ||
| 500 | |a Date Revised 06.02.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 7 | |a Receptor, Cannabinoid, CB1 |2 NLM | |
| 650 | 7 | |a TRPV1 protein, human |2 NLM | |
| 650 | 7 | |a TRPV Cation Channels |2 NLM | |
| 700 | 1 | |a Murri, Martino Belvederi |e verfasserin |4 aut | |
| 700 | 1 | |a Sterlini, Bruno |e verfasserin |4 aut | |
| 700 | 1 | |a Tardito, Samuele |e verfasserin |4 aut | |
| 700 | 1 | |a Altosole, Tiziana |e verfasserin |4 aut | |
| 700 | 1 | |a Bovio, Anna |e verfasserin |4 aut | |
| 700 | 1 | |a da Silva, Beatriz Pereira |e verfasserin |4 aut | |
| 700 | 1 | |a Fenoglio, Daniela |e verfasserin |4 aut | |
| 700 | 1 | |a Filaci, Gilberto |e verfasserin |4 aut | |
| 700 | 1 | |a Amore, Mario |e verfasserin |4 aut | |
| 700 | 1 | |a Serafini, Gianluca |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology |d 1997 |g 79(2024) vom: 01. Feb., Seite 19-21 |w (DE-627)NLM013028618 |x 1873-7862 |7 nnns |
| 773 | 1 | 8 | |g volume:79 |g year:2024 |g day:01 |g month:02 |g pages:19-21 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.euroneuro.2023.10.005 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 79 |j 2024 |b 01 |c 02 |h 19-21 | ||